Patents Assigned to OxaluRx, Inc.
  • Patent number: 11504367
    Abstract: Disclosed herein are compounds and compositions for modulating glycolate oxidase, useful for treating oxalate-related diseases, such as hyperoxaluria, where modulating glycolate oxidase is expected to be therapeutic to a patent in need thereof. Methods of modulating glycolate oxidase activity in a human or animal subject are also provided.
    Type: Grant
    Filed: August 22, 2020
    Date of Patent: November 22, 2022
    Assignee: OxaluRx, Inc.
    Inventors: Ayman Kabakibi, Mehmet Kahraman, Michael Clare, Thomas Leedom
  • Patent number: 11389456
    Abstract: Disclosed herein are compounds and compositions for modulating glycolate oxidase, useful for treating oxalate-related diseases, such as hyperoxaluria, where modulating glycolate oxidase is expected to be therapeutic to a patent in need thereof. Methods of modulating glycolate oxidase activity in a human or animal subject is also provided.
    Type: Grant
    Filed: February 22, 2019
    Date of Patent: July 19, 2022
    Assignee: OxaluRx, Inc.
    Inventors: Bradley T. Keller, John J. Talley